Rossari Biotech profit increased 33.83% in (Q2) FY 2020-21

Source

Team Infinities:

Rossari Biotech Limited NSE Symbol:ROSSARI, BSE Security Code:543213 has declared its 2nd(second) quarter un-audited Consolidated financial report from the month of July, 2020 to the month of September, 2020; for the fiscal year 2020-21.

Revenue Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
175.63 111.07 151.18 286.69 279.77
Calculated Revenue of Rossari Biotech Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
64.56 58.13%(Revenue Increase) 24.45 16.17%(Revenue Increase) 6.92 2.47%(Revenue Increase)

Revenue: Rossari Biotech Limited's financial report shows that the company's revenue increased by 58.13% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for revenue increase of Rs.64.56 crores, as the company posted revenue of Rs.175.63 crores; in compare to previous quarter(April, 2020 - June, 2020) when the company reported revenue of Rs.111.07 crores.
The result also shows that the company's revenue increased by 16.17% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for revenue increase of Rs.24.45 crores; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted revenue of Rs.151.18 crores.
The company also reported that its revenue increased by 2.47% in 6 months end(April, 2020 - September, 2020) for revenue increase of Rs.6.92 crores, since the company reported revenue of Rs.286.69 crores; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted revenue of Rs.279.77 crores.

Gross Margin(%) Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
36.76 39.61 42.19 37.87 36.24
Calculated Gross Margin(%) of Rossari Biotech Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
2.84 7.18%(GM Decrease) 5.42 12.86%(GM Decrease) 1.63 4.51%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 7.18% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for 2.84% GM decrease, as the company reported 36.76% GM; in compare to previous quarter(April, 2020 - June, 2020) when the company reported 39.61% GM.
The result also indicates, the company's GM decreased by 12.86% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for 5.42% GM decrease; in compare to corresponding quarter(July, 2019 - September, 2019) when the company reported 42.19% GM.
The company also reported that its GM increased by 4.51% in 6 months end(April, 2020 - September, 2020) for 1.63% GM increase, since the company reported 37.87% GM; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company reported 36.24% GM.

EBITDA Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
34.03 25.74 29.16 59.76 52.24
Calculated EBITDA of Rossari Biotech Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
8.29 32.21%(EBITDA Increase) 4.87 16.70%(EBITDA Increase) 7.52 14.40%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 32.21% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for EBITDA increase of Rs.8.29 crores, as the company posted EBITDA of Rs.34.03 crores; in compare to previous quarter(April, 2020 - June, 2020) when the company reported EBITDA of Rs.25.74 crores.
The result also shows that the company's EBITDA increased by 16.70% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for EBITDA increase of Rs.4.87 crores; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted EBITDA of Rs.29.16 crores.
The company also reported that its EBITDA increased by 14.40% in 6 months end(April, 2020 - September, 2020) for EBITDA increase of Rs.7.52 crores, since the company reported EBITDA of Rs.59.76 crores; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted EBITDA of Rs.52.24 crores.

Profit and Loss Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
20.73(Profit ) 15.49(Profit ) 17.74(Profit ) 36.22(Profit ) 31.90(Profit )
Calculated Profit and Loss of Rossari Biotech Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
5.24 33.83%(Profit Increase) 2.99 16.85%(Profit Increase) 4.32 13.54%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 33.83% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for profit increase of Rs.5.24 crores, as the company posted profit of Rs.20.73 crores; in compare to previous quarter(April, 2020 - June, 2020) when the company reported profit of Rs.15.49 crores.
The result also shows that the company's profit increased by 16.85% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for profit increase of Rs.2.99 crores; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted profit of Rs.17.74 crores.
The company also reported that its profit increased by 13.54% in 6 months end(April, 2020 - September, 2020) for profit increase of Rs.4.32 crores, since the company reported profit of Rs.36.22 crores; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted profit of Rs.31.90 crores.

EPS Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Current Quarter (July, 2020 - September, 2020) Previous Quarter (April, 2020 - June, 2020) Corresponding Quarter (July, 2019 - September, 2019) 6 Months Ended (April, 2020 - September, 2020) Corresponding 6 Months Ended (April, 2019 - September, 2019)
4.07 3.19 3.66 7.11 6.59
Calculated EPS of Rossari Biotech Limited for Second Quarter FY, 2020-21
Current(September, 2020) VS Previous(June, 2020) Current(September, 2020) VS Corresponding(September, 2019) 6 months Ended(April, 2020 - September, 2020) VS Corresponding 6 months Ended(April, 2019 - September, 2019)
Change Change % Change Change % Change Change %
0.88 27.59%(EPS Increase) 0.41 11.20%(EPS Increase) 0.52 7.89%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 27.59% in QoQ(Quarter on Quarter) / current quarter(July, 2020 - September, 2020) for EPS increase of Rs.0.88, as the company posted EPS of Rs.4.07; in compare to previous quarter(April, 2020 - June, 2020) when the company reported EPS of Rs.3.19.
The result also shows that the company's EPS increased by 11.20% in YoY(Year over Year) / in current quarter(July, 2020 - September, 2020) for EPS increase of Rs.0.41; in compare to corresponding quarter(July, 2019 - September, 2019) when the company posted EPS of Rs.3.66.
The company also reported that its EPS increased by 7.89% in 6 months end(April, 2020 - September, 2020) for EPS increase of Rs.0.52, since the company reported EPS of Rs.7.11; in compare to corresponding 6 months end(April, 2019 - September. 2019) when the company posted EPS of Rs.6.59.

Assets Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Details Non-current Assets Current Assets
Current Year Ended(September, 2020) Previous Year End(March, 2020) Current Year Ended(September, 2020) Previous Year End(March, 2020)
Reported 176.41 145.19 310.32 326.32
  Change Change % Change Change %
Calculated 31.22 21.50%(Assets Increase) 16.00 4.90%(Assets Decrease)

Assets:The company reported its non-current assets increased by 21.50% in current quarter(September, 2020) for non-current assets increase of Rs.31.22 crores, since the company reported net non-current assets of Rs.176.41 crores; in compare to previous year end(March, 2020) when the company reported net non-current assets of Rs.145.19 crores.
The balance sheet of the company also shows that, its current assets decreased by 4.90% in current quarter(September, 2020) for current assets decrease of Rs.16.00 crores, as the company reported net current assets of Rs.310.32 crores; against previous year end(March, 2020) when the company reported net current assets of Rs.326.32 crores.

Liabilities Reported by Rossari Biotech Limited for Second Quarter FY, 2020-21
Details Non-current Liabilities Current Liabilities
Current Year Ended(September, 2020) Previous Year End(March, 2020) Current Year Ended(September, 2020) Previous Year End(March, 2020)
Reported 2.26 36.13 120.63 148.71
  Change Change % Change Change %
Calculated 33.87 93.74%(Liabilities Decrease) 28.08 18.88%(Liabilities Decrease)

Liabilities:The company reported its non-current liabilities decreased by 93.74% in current quarter(September, 2020) for non-current liabilities decrease of Rs.33.87 crores, since the company reported net non-current liabilities of Rs.2.26 crores; in compare to previous year end(March, 2020) when the company reported net non-current liabilities of Rs.36.13 crores.
The balance sheet of the company also shows that, its current liabilities decreased by 18.88% in current quarter(September, 2020) for current liabilities decrease of Rs.28.08 crores, as the company reported net current liabilities of Rs.120.63 crores; against previous year end(March, 2020) when the company reported net current liabilities of Rs.148.71 crores.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.